Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Serious Herbal AEs Deemed Negligible; AHPA Urges Mandatory Reporting

This article was originally published in The Tan Sheet

Executive Summary

Mandatory adverse event reporting would not harm the botanicals industry because the number of serious adverse events for such products is extremely small, AHPA's board has concluded
Advertisement

Related Content

Firms Need To Commit More Time, Money To Industry Cause – DSEA’s Balbert
Firms Need To Commit More Time, Money To Industry Cause – DSEA’s Balbert
Firms Need To Commit More Time, Money To Industry Cause – DSEA’s Balbert
Adverse Event Bill Down To The Wire As Congress Wraps Up
Adverse Event Bill Down To The Wire As Congress Wraps Up
Trade Group Efforts, Timing Bring AER System Concerns To Fore
Mandatory Supplement AE Reporting Possible Under Current Law – AHPA
Metabolife Federal Probe Spurs Release Of Ephedrine Complaint Records
Herbal Regulatory Category Creation At FDA Suggested By Sen. Durbin
Herbal Regulatory Category Creation At FDA Suggested By Sen. Durbin

Topics

Advertisement
UsernamePublicRestriction

Register

PS094630

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel